Comparison of survival benefit of panitumumab with supportive care to best supportive care alone in patients with metastatic colorectal cancer

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-022951-49

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To evaluate the effect of panitumumab and best supportive care (BSC) versus BSC alone on overall survival (OS) in subjects with chemorefractory wild-type codons 12 and 13 Kirsten rat sarcoma viral oncogene homolog (KRAS) mCRC


Critère d'inclusion

  • Chemorefractory, Wild-type Kirsten rat sarcoma viral oncogene homolog (KRAS), Metastatic Colorectal Cancer